Bosh sahifaSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Yopilish kursi
266,40 kr
Kunlik diapazon
260,00 kr - 264,40 kr
Yillik diapazon
241,80 kr - 354,40 kr
Bozor kapitalizatsiyasi
93,63 mlrd SEK
Oʻrtacha hajm
366,12 ming
Narx/foyda
23,39
Dividend daromadliligi
-
Asosiy maydon
STO
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,44 mlrd | 8,65% |
Joriy xarajat | 4,17 mlrd | 15,32% |
Sof foyda | 1,40 mlrd | 36,16% |
Sof foyda marjasi | 18,79 | 25,35% |
Har bir ulushga tushum | 3,98 | 25,16% |
EBITDA | 2,34 mlrd | -6,42% |
Amaldagi soliq stavkasi | 3,27% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,14 mlrd | 26,11% |
Jami aktivlari | 75,44 mlrd | 1,91% |
Jami passivlari | 35,15 mlrd | -12,48% |
Umumiy kapital | 40,30 mlrd | — |
Tarqatilgan aksiyalar | 343,44 mln | — |
Narxi/balansdagi bahosi | 2,27 | — |
Aktivlardan daromad | 5,53% | — |
Kapitaldan daromad | 7,29% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,40 mlrd | 36,16% |
Operatsiyalardan naqd pul | 1,80 mlrd | 67,63% |
Sarmoyadan naqd pul | -101,00 mln | 77,95% |
Moliyadan naqd pul | -1,15 mlrd | -221,23% |
Naqd pulning sof oʻzgarishi | 546,00 mln | 141,59% |
Boʻsh pul | 2,90 mlrd | 375,08% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 806
